|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Type 2 Diabetes | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Diabetes Mellitus, Type 2 | |||||
| Insulin Resistance | |||||
| 3 | More general conditions related to this trial | ||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Hyperinsulinism | |||||
| Metabolic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| Shanghai Jiao Tong University of Medicine | |||||